Oscar Health (NYSE:OSCR) Stock Rating Reaffirmed by Piper Sandler

Piper Sandler reiterated their overweight rating on shares of Oscar Health (NYSE:OSCR) in a research note published on Tuesday morning, Benzinga reports. The brokerage currently has a $28.00 price target on the stock.

OSCR has been the topic of a number of other research reports. Bank of America reiterated a neutral rating and set a $21.00 target price (down previously from $25.00) on shares of Oscar Health in a research report on Thursday, May 30th. Wells Fargo & Company boosted their target price on shares of Oscar Health from $24.00 to $27.00 and gave the company an overweight rating in a research report on Wednesday, June 12th. Baird R W upgraded shares of Oscar Health to a strong-buy rating in a research report on Thursday, May 30th. Finally, Robert W. Baird started coverage on shares of Oscar Health in a research report on Thursday, May 30th. They set an outperform rating and a $28.00 target price on the stock. Two investment analysts have rated the stock with a hold rating, four have issued a buy rating and one has assigned a strong buy rating to the company’s stock. Based on data from MarketBeat, the stock has an average rating of Moderate Buy and a consensus price target of $24.17.

Oscar Health Trading Up 2.9 %

NYSE:OSCR opened at $21.60 on Tuesday. The firm’s fifty day moving average is $17.27 and its 200-day moving average is $17.33. The company has a debt-to-equity ratio of 0.26, a quick ratio of 0.91 and a current ratio of 0.91. Oscar Health has a 52 week low of $4.72 and a 52 week high of $23.44. The firm has a market cap of $5.23 billion, a P/E ratio of -54.00, a P/E/G ratio of 40.95 and a beta of 1.61.

Oscar Health (NYSE:OSCR) last released its earnings results on Wednesday, August 7th. The company reported $0.20 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.16 by $0.04. Oscar Health had a net margin of 0.25% and a return on equity of 1.86%. The company had revenue of $2.20 billion for the quarter, compared to the consensus estimate of $2.13 billion. During the same quarter in the previous year, the company earned ($0.07) EPS. Oscar Health’s quarterly revenue was up 44.6% compared to the same quarter last year. Equities analysts expect that Oscar Health will post 0.01 earnings per share for the current year.

Insiders Place Their Bets

In other news, insider Mario Schlosser sold 3,198 shares of the company’s stock in a transaction on Tuesday, September 3rd. The shares were sold at an average price of $17.99, for a total value of $57,532.02. Following the completion of the sale, the insider now owns 76,982 shares in the company, valued at approximately $1,384,906.18. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. In other news, insider Mario Schlosser sold 3,198 shares of the company’s stock in a transaction on Tuesday, September 3rd. The shares were sold at an average price of $17.99, for a total value of $57,532.02. Following the completion of the sale, the insider now owns 76,982 shares in the company, valued at approximately $1,384,906.18. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, CAO Victoria Baltrus sold 4,226 shares of the company’s stock in a transaction on Tuesday, September 3rd. The stock was sold at an average price of $17.99, for a total transaction of $76,025.74. Following the completion of the sale, the chief accounting officer now owns 140,648 shares of the company’s stock, valued at approximately $2,530,257.52. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 169,569 shares of company stock worth $3,007,069. Insiders own 25.11% of the company’s stock.

Hedge Funds Weigh In On Oscar Health

Several institutional investors have recently added to or reduced their stakes in OSCR. New York State Common Retirement Fund grew its position in Oscar Health by 3.8% during the fourth quarter. New York State Common Retirement Fund now owns 64,856 shares of the company’s stock valued at $593,000 after buying an additional 2,394 shares during the period. Victory Capital Management Inc. grew its position in Oscar Health by 37.7% during the fourth quarter. Victory Capital Management Inc. now owns 18,852 shares of the company’s stock valued at $172,000 after buying an additional 5,159 shares during the period. National Bank of Canada FI bought a new position in Oscar Health during the fourth quarter valued at about $1,071,000. Charles Schwab Investment Management Inc. grew its position in Oscar Health by 3.1% during the fourth quarter. Charles Schwab Investment Management Inc. now owns 1,160,483 shares of the company’s stock valued at $10,618,000 after buying an additional 35,128 shares during the period. Finally, Teacher Retirement System of Texas bought a new position in Oscar Health during the fourth quarter valued at about $406,000. Institutional investors own 75.70% of the company’s stock.

Oscar Health Company Profile

Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.